Fingerprint
Dive into the research topics of 'A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients
Aminah Jatoi, Carmen Radecki Breitkopf, Nathan R. Foster, Matthew S. Block, Megan Grudem, Andrea Wahner Hendrickson, Rachel E. Carlson, Brigitte Barrette, Nina Karlin, Alan P. Fields
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations